MedX Health Corp., a medical device and software company, develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, Australia, Asia, and Latin America. More Details
Limited growth with imperfect balance sheet.
Share Price & News
How has MedX Health's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: MDXH.F has not had significant price volatility in the past 3 months.
7 Day Return
US Medical Equipment
1 Year Return
US Medical Equipment
Return vs Industry: Insufficient data to determine how MDXH.F performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how MDXH.F performed against the US Market.
Price Volatility Vs. Market
How volatile is MedX Health's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is MedX Health undervalued compared to its fair value and its price relative to the market?
In this section, we usually try to help investors determine whether MedX Health is trading at an attractive price based on the cash flow it is expected to produce in the future. But as MedX Health has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.
This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.
- Take a look at our analysis of MDXH.F's management and see if the CEO's compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
- When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don't know where to start, we recommend reading through MedX Health regulatory filings here.
- Explore potentially undervalued companies in the Healthcare industry.
How is MedX Health forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Forecasted annual revenue growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if MDXH.F's forecast earnings growth is above the savings rate (2.2%).
Earnings vs Market: Insufficient data to determine if MDXH.F's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: MDXH.F's revenue (145.8% per year) is forecast to grow faster than the US market (9.9% per year).
High Growth Revenue: MDXH.F's revenue (145.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if MDXH.F's Return on Equity is forecast to be high in 3 years time
How has MedX Health performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: MDXH.F is currently unprofitable.
Growing Profit Margin: MDXH.F is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: MDXH.F is unprofitable, and losses have increased over the past 5 years at a rate of 35.7% per year.
Accelerating Growth: Unable to compare MDXH.F's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MDXH.F is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (1.8%).
Return on Equity
High ROE: MDXH.F's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.
How is MedX Health's financial position?
Financial Position Analysis
Short Term Liabilities: MDXH.F has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: MDXH.F has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: MDXH.F has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: MDXH.F's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MDXH.F has sufficient cash runway for 2 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: MDXH.F is forecast to have sufficient cash runway for 2 months based on free cash flow estimates, but has since raised additional capital.
What is MedX Health current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate MDXH.F's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate MDXH.F's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if MDXH.F's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if MDXH.F's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of MDXH.F's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Rob von der Porten
Mr. Robert von der Porten, also known as Rob, MBA, BA, has been Chairman of the Board of MedX Health Corp. from September 18, 2018 and serves as its Director since November 29, 2013. Mr. von der Porten ser ...
CEO Compensation Analysis
Compensation vs Market: Rob's total compensation ($USD0.00) is below average for companies of similar size in the US market ($USD601.03K).
Compensation vs Earnings: Rob's compensation has increased whilst the company is unprofitable.
|Chief Financial Officer||6.83yrs||CA$205.89k||0.26% |
|COO & MD of Light Therapy Products||6.67yrs||CA$210.85k||0.25% |
|Vice President of Sales||13.25yrs||CA$63.29k||no data|
|Managing Director of Europe||4.5yrs||no data||no data|
|Managing Director of US Operations||3.75yrs||no data||no data|
|President of Dermatological Services & Products||no data||no data||no data|
|Managing Director of EMEA||no data||no data||no data|
|Secretary||no data||no data||no data|
Experienced Management: MDXH.F's management team is seasoned and experienced (5.6 years average tenure).
|Independent Director||18.83yrs||no data||0.13% |
|Independent Director||18.83yrs||no data||1.43% |
|Independent Director||18.83yrs||no data||0.49% |
|Member of Medical Advisory Board||1.92yrs||no data||no data|
|Member of Medical/Scientific Advisory Board||3.33yrs||no data||no data|
|Member of Medical Advisory Board||2.33yrs||no data||no data|
|Independent Director||4.83yrs||no data||no data|
|Member of Medical/Scientific Advisory Board||3.5yrs||no data||no data|
|Member of Medical Advisory Board||2.08yrs||no data||no data|
|Member of Medical Advisory Board||1.75yrs||no data||no data|
|Member of Medical Advisory Board||no data||no data||no data|
Experienced Board: MDXH.F's board of directors are considered experienced (3.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 23.6%.
MedX Health Corp's company bio, employee growth, exchange listings and data sources
- Name: MedX Health Corp
- Ticker: MDXH.F
- Exchange: OTCPK
- Founded: 1999
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: CA$21.928m
- Listing Market Cap: CA$16.365m
- Shares outstanding: 175.42m
- Website: https://www.medxhealth.com
- MedX Health Corp
- 1495 Bonhill Road
- Unit #1
- L5T 1M2
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|MDX||TSXV (TSX Venture Exchange)||Yes||Common Shares||CA||CAD||Feb 2008|
|9MH||DB (Deutsche Boerse AG)||Yes||Common Shares||DE||EUR||Feb 2008|
|MDXH.F||OTCPK (Pink Sheets LLC)||Yes||Common Shares||US||USD||Feb 2008|
MedX Health Corp., a medical device and software company, develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United S ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/09/30 00:08|
|End of Day Share Price||2020/09/29 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.